jueves, 30 de agosto de 2018

Multiple Myeloma | Myeloma | Multiple Myeloma Symptoms  | MedlinePlus

Multiple Myeloma | Myeloma | Multiple Myeloma Symptoms  | MedlinePlus

MedlinePlus Trusted Health Information for You

Multiple Myeloma

Also called: Plasma-cell myeloma

Multiple Myeloma

National Institutes of Health

The primary NIH organization for research on Multiple Myeloma is theNational Cancer Institute


MedlinePlus links to health information from the National Institutes of Health and other federal government agencies. MedlinePlus also links to health information from non-government Web sites. See our disclaimer about external links and our quality guidelines.

New on the MedlinePlus Multiple Myeloma page:
08/23/2018 02:26 PM EDT

From the National Institutes of Health


Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. These cells are part of your immune system, which helps protect the body from germs and other harmful substances. In time, myeloma cells collect in the bone marrow and in the solid parts of bones.
No one knows the exact causes of multiple myeloma, but it is more common in older people and African Americans. It can run in families. Common symptoms may include
  • Bone pain, often in the back or ribs
  • Broken bones
  • Weakness or fatigue
  • Weight loss
  • Frequent infections and fevers
  • Feeling very thirsty
  • Frequent urination
Doctors diagnose multiple myeloma using lab tests, imaging tests, and a bone marrow biopsy. Your treatment depends on how advanced the disease is and whether you have symptoms. If you have no symptoms, you may not need treatment right away. If you have symptoms, you may have chemotherapy, stem cell transplantation, radiation, or targeted therapy. Targeted therapy uses substances that attack cancer cells without harming normal cells.
NIH: National Cancer Institute

Start Here


Diagnosis and Tests

Treatments and Therapies

Living With

Related Issues


Statistics and Research

Clinical Trials

Patient Handouts

No hay comentarios:

Publicar un comentario